From risk factors to molecular targets: clinical associations and molecular docking insights into phthalate-associated diabetic retinopathy

• by Zhiwei Xu, Shi Bai, Caidi He, Xiaobei Lv, Qin Li, Qile Mao, Haijian Wu, Peter Wang

• May 13, 2026

Semaglutide Linked to NAION Risk

A retrospective database study found a low absolute incidence but higher relative hazard of ischemic optic neuropathy following semaglutide initiation.

• by Andrea Surnit

• May 11, 2026

• 3 min

Advocacy Pays Off for ASCs

At the Outpatient Ophthalmic Surgery Society’s “OOSS Perspective 2026” symposium in Washington, DC, the organization's Washington counsel, Michael Romansky, JD, delivered an update on reimbursement, regulatory developments, and advocacy priorities affecting ophthalmic ambulatory surgery centers (ASCs).

• by Jennifer Ford, content director, Jennifer Ford, content director

• May 1, 2026

• 4 min

Eye on OOSS: Advocacy Matters, and It Works

In an increasingly complex health care environment, the combination of strong advocacy, collaborative learning, and access to actionable resources, positions OOSS members for continued success.

• by Diane Blanck, Diane Blanck

• May 1, 2026

• 6 min